Home Compare BAYN.DE vs GILD
Stock Comparison · Industry comparison · Drug Manufacturers - General

Bayer Aktiengesellschaft vs Gilead Sciences: Which Stock Looks Stronger in 2026?

Gilead Sciences holds the cleaner structural position, with the lead spread across stability and profitability. Bayer Aktiengesellschaft still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (BAYN.DE: DAX 40, GILD: Nasdaq 100).

Updated 2026-05-17

The lead is spread across stability and profitability, rather than sitting in one isolated gap. The overall score gap is 16 points in favour of Gilead Sciences, Inc..

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. BAYN.DE and GILD share the same industry classification.

For a similarity-based comparison, see how Bayer Aktiengesellschaft and Gilead Sciences each position within their functional peer groups in AssetNext.

Peer-Relative Score
BAYN.DE
Bayer Aktiengesellschaft
58
Peer-Score
Signal qualitylow
Peer basis: DAX 40
vs
GILD
Gilead Sciences, Inc.
74
Peer-Score
Signal qualitylow
Peer basis: Nasdaq 100

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: BAYN.DE vs GILD Profitability 36 74 Stability 31 75 Valuation 83 85 Growth 79 56 BAYN.DE GILD
Gap Ranking
#1 Stability +44
#2 Profitability +38
#3 Growth +23
#4 Valuation +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BAYN.DE and GILD Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BAYN.DEGILD Relative valuation Structural strength

Gilead Sciences, Inc. is cheaper, but Bayer Aktiengesellschaft is still stronger.

Valuation position uses Forward P/E and peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where BAYN.DE and GILD each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY BAYN.DE Neutral · below norm 0th 50th 100th 51 pct gap GILD Elevated · near norm 0th 50th 100th 43rd 94th
Today BAYN.DE sits in the lower-middle of its own 5-year history (43rd percentile), while GILD sits higher in its own history (94th). Within each stock's own 5-year context, BAYN.DE is at a historically more favourable entry position than GILD. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Stability
Gilead Sciences, Inc. ranks near the top of the group on stability; Bayer Aktiengesellschaft sits in the weaker half.
Profitability
On profitability, the gap still runs the same way: Gilead Sciences, Inc. sits near the top of the group, while Bayer Aktiengesellschaft remains in the weaker half.
Stability — Dominant Gap
BAYN.DE
31
GILD
75
Gap+44in favour of GILD

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

Earnings growth also leans toward BAYN.DE, which keeps the score lead from reading as a full growth sweep.

What this means for the comparison

The lead is built on both stability and profitability — though growth still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the BAYN.DE vs GILD comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BAYN.DE and GILD each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.